Grove AI References Capped?

Access even more references from these marketplace competitors

  • 4.8 / 5.0 (86)
    4+ References
  • 4.8 / 5.0 (158)
    15+ References
  • 4.7 / 5.0 (292)
    11+ References

Grove AI

Read 2 Grove AI reviews and testimonials from customers, explore 3 case studies and customer success stories, and watch customer videos to see why companies chose Grove AI as their AI for Healthcare

Grove's AI-accelerated PRM enables clinical research organizations to recruit and engage with participants at scale. At Grove, they’re committed to building purposeful, people-centric, and safe innovations to serve their communities. They’re deeply grateful to their investors, partners, and clinical research leaders—from site coordinators to patient advocates to clinical operations executives—for supporting their mission to advance clinical trials.

Show more
  • 2 Testimonials View
  • 3 Case Studies View
  • No
    Videos Yet
    Customer Videos
Customer Rating Review Score based on 287 reference ratings
4.8/5.0 (287)

2Testimonials

  • "In just two months of partnering with Grove, we transformed how our teams operate and engage with participants. We prescreened and booked hundreds of participants for our Alzheimer’s and vaccine …

  • "Grove's data-driven AI solutions have been transformative for Celerion, significantly optimizing our clinical trial processes. We saw a 28% increase in screening pass rates for trials, and their AI agent …

1 more testimonials currently locked

3 Case Studies

  • Leading Site Network Schedules 580% More Participants with Grove AI

  • Celerion Increases Screening Pass Rate by 28% with Grove AI

  • K2 Medical Research Accelerates Recruitment for 50+ Years Old Demographic with Grove …

2 more case studies currently locked

Additional Grove AI Information & Resources

Read Grove AI Reviews, Testimonials & Customer References from 2 real Grove AI customers.

Browse Grove AI Case Studies, Customer Success Stories, & Customer References from 3 businesses that use Grove AI.